Skip header and navigation

8 records – page 1 of 1.

Document Type
Table
Review Code
EOC210901 RR Table
Question Submitted
September 21, 2021
Date Completed
September 30, 2021
Status
3. Completed
Research Team
EOC
Document Type
Table
Review Code
EOC210901 RR Table
Question Submitted
September 21, 2021
Date Completed
September 30, 2021
Status
3. Completed
Research Team
EOC
Category
Infection Prevention and Control
Subject
Face Masks
Pediatrics
Public Health
Schools
Population
All Pediatrics
All adults
Clinical Setting
Public Health
Priority Level
Level 4 Three weeks (21 days)
Cite As
Badea, A; Groot, G; Muhajarine, N; Howell-Spooner, B; Young, C. What is the evidence for the effectiveness of universal mask use in the pediatric population? 2021 Sep 30, Document no.: EOC210901 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2021. (CESTtable).
Related Documents
Documents

EOC210901 RR Table

Download File
Less detail
Document Type
Rapid Review
Review Code
EOC210901 RR
Question Submitted
September 21, 2021
Date Completed
September 30, 2021
Status
3. Completed
Research Team
EOC
Document Type
Rapid Review
Review Code
EOC210901 RR
Question Submitted
September 21, 2021
Date Completed
September 30, 2021
Status
3. Completed
Research Team
EOC
Key Findings
September 30, 2021
Studies conducted before mass vaccination campaigns began have reported proper and consistent facemasking by students and staff in school settings are associated with reduced incidence of school-associated transmission or seropositivity.
Fewer studies have reported efficacy of facemasking in the post-mass vaccination period in school settings. The studies available report, however, school-associated transmission were lower, less than 1% secondary attack rate in schools.
Studies of school-associated COVID-19 cases find community exposure to SARS-CoV-2 and/or noncompliance with multiple mitigation measures (e.g. facemask policies, distancing, non-isolation, etc) are key factors of clusters and outbreaks in children.
Category
Infection Prevention and Control
Subject
Face Masks
Public Health
Schools
Pediatrics
Population
All Pediatrics
All adults
Clinical Setting
Public Health
Priority Level
Level 4 Three weeks (21 days)
Cite As
Badea, A; Groot, G; Muhajarine, N; Howell-Spooner, B; Young, C. What is the evidence for the effectiveness of universal mask use in the pediatric population? 2021 Sep 30, Document no.: EOC210901 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2021. 14 p. (CEST rapid review report).
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
EOC062301v3 RR
Question Submitted
June 23, 2020
Date Completed
December 1, 2020
Status
5. Updated review
Research Team
EOC
Document Type
Rapid Review
Review Code
EOC062301v3 RR
Question Submitted
June 23, 2020
Date Completed
December 1, 2020
Status
5. Updated review
Research Team
EOC
Key Findings
Systematic reviews indicate there is a growing evidence in support of a correlation between mask use and lowered risk of SARS-CoV-2 infection
Case-control and observational studies have demonstrated a positive effect on community transmission rates
Masks provide the greatest community impact when implemented early, adherence is high and when combined with social distancing and hand hygiene
Individual protection is largely impacted by mask material and fit
Mask use is considered an adjunct to, rather than a replacement for, other non-pharmaceutical public health measures (social distancing, hand-washing)
Category
Infection Prevention and Control
Subject
Personal Protective Equipment
Face Masks
Public Health
Population
All
Clinical Setting
Public Health
Priority Level
Level 4 completed within 1 week
Cite As
Badea, A; Groot, G; Howell-Spooner, B; Young, C. What is the evidence for the effectiveness of universal mask use by the public? 2020 Dec 1; Document no.: EOC062301v3 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 33 p. (CEST rapid review report)
Review History
EOC062301 RR: August 9, 2020
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
PPE110201 RR
Question Submitted
November 2, 2020
Date Completed
November 20, 2020
Status
3. Completed
Research Team
Personal Protective Equipment
Document Type
Rapid Review
Review Code
PPE110201 RR
Question Submitted
November 2, 2020
Date Completed
November 20, 2020
Status
3. Completed
Research Team
Personal Protective Equipment
Key Findings
N95 respirators that have been reprocessed demonstrate acceptable fit and filtration performance under laboratory conditions
Increased use over time both in terms of length of wear and number of donning/doffings increases the likelihood of fit failure
Reprocessing masks does not render them to ‘new’ condition
Category
Infection Prevention and Control
Subject
Face Masks
Health Personnel
Population
Other
Clinical Setting
Other
all clinical (and non) settings
Priority Level
Level 4 Three weeks (21 days)
Cite As
Badea, A; Groot, G; Dalidowicz, M; Miller, L. What is the evidence to support the reprocessing and re-use of N95 respirators by healthcare workers? 2020 Nov 20; Document no.: PPE110201 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 19 p. (CEST rapid review report)
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
PPE110203 RR
Question Submitted
November 2, 2020
Date Completed
November 20, 2020
Status
3. Completed
Research Team
Personal Protective Equipment
Document Type
Rapid Review
Review Code
PPE110203 RR
Question Submitted
November 2, 2020
Date Completed
November 20, 2020
Status
3. Completed
Research Team
Personal Protective Equipment
Key Findings
Laboratory testing of expired masks maintain an acceptable filtration performance with less than 2% failing testing in a study of nearly 4,000 masks from 93 lots
Another study assessing stockpiled N95 masks in Taiwan found acceptable filtration up to 13 years post storage
Guidelines indicate that expired N95 respirators should be used before resorting to extended use/reuse
Category
Infection Prevention and Control
Subject
Face Masks
Health Personnel
Population
All
Priority Level
Level 3 Two weeks (14 days)
Cite As
Badea, A; Groot, G; Dalidowicz, M; Miller, L. What evidence is available regarding degradation of N95 respirators/masks? 2020 Nov 20; Document no.: PPE110203 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 15 p. (CEST rapid review report)
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
EOC102001 RR
Question Submitted
October 20, 2020
Date Completed
October 26, 2020
Status
3. Completed
Research Team
EOC
Document Type
Rapid Review
Review Code
EOC102001 RR
Question Submitted
October 20, 2020
Date Completed
October 26, 2020
Status
3. Completed
Research Team
EOC
Key Findings
Mask wearing causes respiratory changes in respiration efforts, air resistance and sensation of dyspnea, but these do not appear to be clinically significant
A number of studies have assessed the use of N95 masks under low-moderate work conditions, concluding that mask wearing is well tolerated by healthy individuals
Limited evidence in special populations indicates that those with very severe conditions may be unable to tolerate mask wearing
Category
Infection Prevention and Control
Subject
Risk
Face Masks
Population
All
Priority Level
Level 2 One week (7 days)
Cite As
Badea, A; Groot, G; Young, C; Miller, L. What are the risks of long-term and/or continuous mask use? 2020 Oct 20; Document no.: EOC102001 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 21 p. (CEST rapid review report)
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
EOC091101 RR
Question Submitted
September 11, 2020
Date Completed
September 17, 2020
Status
3. Completed
Research Team
EOC
Document Type
Rapid Review
Review Code
EOC091101 RR
Question Submitted
September 11, 2020
Date Completed
September 17, 2020
Status
3. Completed
Research Team
EOC
Key Findings
The evidence to support medical exemptions for mask wearing is limited. The predominant discourse revolves around a risk-based approach that considers the potential benefits and harms for individuals; few absolute exceptions to masking have been advocated. Masks are one part of a comprehensive strategy to reduce the spread of SARS CoV-2 infection and should be viewed in the context of other public health measures including physical distancing, hand hygiene and respiratory etiquette.
Category
Infection Prevention and Control
Subject
Face Masks
Population
All
Clinical Setting
Community
Public Health
Priority Level
Level 3 completed within 2-3 days
Cite As
Williams-Roberts, H; McLean, M; Groot, G; Young, C; Mueller, M; Miller, L. What evidence is there to support medical exemptions for mask wearing? 2020 Sep 17; Document no.: EOC091101 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 20 p. (CEST rapid review report)
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
EOC040601 RR
Question Submitted
April 6, 2020
Date Completed
April 6, 2020
Status
3. Completed
Research Team
EOC
Document Type
Rapid Review
Review Code
EOC040601 RR
Question Submitted
April 6, 2020
Date Completed
April 6, 2020
Status
3. Completed
Research Team
EOC
Key Findings
Surgical masks are superior to cloth masks in their ability to block particles
Small scale studies to support reduced transmission in practice
Several mechanical studies indicating meager protection
Evidence supports current national recommendations to combine mask use with proper hand hygiene and above all, proper distancing measures
Category
Infection Prevention and Control
Healthcare Services
Subject
Personal Protective Equipment
Face Masks
Population
All
Clinical Setting
Community
Priority Level
Level 1 completed within 4 hours
Cite As
Badea, A; Groot, G; Dalidowicz, M; Young, C. What is the evidence for the effectiveness of face masks for preventing the spread of COVID-19 in the community? 2020 Apr 6; Document no.: EOC040601 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 8 p. (CEST rapid review report)
Related Documents
Documents
Less detail

8 records – page 1 of 1.